Proteomic and microRNA‑omic profiles and potential mechanisms of dysfunction in pancreatic islet cells primed by inflammation
Open Access
- 3 December 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (2), 1
- https://doi.org/10.3892/etm.2020.9554
Abstract
Diabetes is an inflammatory disease that induces pancreatic islet dysfunction. However, to the best of our knowledge, the potential underlying molecular mechanisms of this inflammatory process remains unknown. The present study investigated microRNA (miRNA/miR) and protein expression profiles through proteomics and miRNA‑omics. Lipopolysaccharide‑induced macrophage cell medium (LRM) was used to stimulate inflammation in mouse Beta‑TC‑6 islet cells. Protein analysis revealed that 87 proteins were upregulated and 42 proteins were downregulated in LRM‑treated Beta‑TC‑6 cells compared with control cells. Additionally, miRNA analysis revealed that 11 miRNAs were upregulated, while 28 miRNAs were downregulated in LRM‑treated Beta‑TC‑6 cells compared with control cells. Islet cells exposed to inflammation exhibited markedly downregulated protein levels of transcription factor MafA, pancreatic and duodenal homeobox 1, paired box 6, homeobox protein Nkx‑2.2, synaptosomal‑associated protein 25, glucagon and insulin‑2, while the expression of miR‑146a‑5p and miR‑21a‑5p were upregulated. It was also determined that upregulated miR‑146a‑5p and miR‑21a‑5p levels may be mediated by NF‑κB activation. The downregulation of islet functional factor mRNA was partially reversed by treating islet cells with an inhibitor of miR‑21a‑5p. However, treatment with an miR‑146a‑5p inhibitor did not exert the same effect. Overall, the present study determined the molecular profiles of islet cell inflammation based on proteomics and miRNA‑omics, and indicated that the proteins and miRNAs with altered expressions may form a large network that serves a role in islet dysfunction. Particularly, miR‑21a‑5p upregulation in response to inflammation may contribute to islet cell dysfunction. However, how these miRNAs regulated the expression of certain mRNAs and proteins in islet cell inflammation requires further investigation.Keywords
This publication has 39 references indexed in Scilit:
- Emerging technologies for the prevention and management of diabetic foot ulcersJournal of Tissue Viability, 2020
- Mechanistic Computational Models of MicroRNA-Mediated Signaling Networks in Human DiseasesInternational Journal of Molecular Sciences, 2019
- MiR-30a targets IL-1α and regulates islet functions as an inflammation buffer and response factorScientific Reports, 2017
- Pancreatic islet inflammation: an emerging role for chemokinesJournal of Molecular Endocrinology, 2017
- Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013Jama-Journal Of The American Medical Association, 2017
- MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune DiabetesBioMed Research International, 2015
- Islet inflammation in human type 1 diabetes mellitusIUBMB Life, 2014
- Diabetes is an inflammatory disease: evidence from traditional Chinese medicinesDiabetes, Obesity and Metabolism, 2011
- β-Cell death during progression to diabetesNature, 2001
- The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell, 1993